Publications by authors named "Victor Biton"

Claim this Profile
P
Pharmacokinetics and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescents.
Pavel Klein, Gewalin Aungaroon, Victor Biton, Kore Kai Liow, Steven Phillips

Epilepsia· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study.
Vineet Punia, Pavel Klein, Temenuzhka Mihaylova, Victor Biton, Omar Samad

J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination.
Jacqueline French, Victor Biton, Hina Dave, Kamil Detyniecki, Michael A Gelfand

Epilepsia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analysis of a phase 3 study for treatment of uncontrolled focal seizures: Adjunctive cenobamate dose and seizure reduction by baseline seizure frequency.
Sami Aboumatar, Victor Biton, Robert Wechsler, Louis Ferrari, William E Rosenfeld

Epilepsy Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Philippe Ryvlin, Svetlana Dimova, Sami Elmoufti, Florin Floricel, Cédric Laloyaux, Victor Biton

Epilepsia· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program.
Josemir W Sander, William E Rosenfeld, Jonathan J Halford, Bernhard J Steinhoff, Victor Biton

Epilepsia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analysis of a phase 3, multicenter, open-label study of cenobamate for treatment of uncontrolled focal seizures: Effects of dose adjustments of concomitant antiseizure medications.
William E Rosenfeld, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton

Epilepsia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
Michael R Sperling, Bassel Abou-Khalil, Sami Aboumatar, Perminder Bhatia, Victor Biton

Epilepsia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.
James W Wheless, Ian Miller, R Edward Hogan, Dennis Dlugos, Victor Biton

Epilepsia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent safety and tolerability of Valtoco (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long-term, open-label, repeat-dose safety study.
Ian Miller, James W Wheless, Robert E Hogan, Dennis Dlugos, Victor Biton

Epilepsia Open· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
Eric B Segal, Daniel Tarquinio, Ian Miller, James W Wheless, Dennis Dlugos, Victor Biton

Epilepsia· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety, efficacy, and quality of life outcomes with adjunctive brivaracetam treatment at individualized doses in patients with epilepsy: An up to 11-year, open-label, follow-up trial.
Terence J O'Brien, Simon Borghs, Qin Jane He, Anne-Liv Schulz, Stephen Yates, Victor Biton

Epilepsia· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy.
Elinor Ben-Menachem, Hans Peter Grebe, Kiyohito Terada, Lori Jensen, Ting Li, Victor Biton

Epilepsia· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Eva Andermann, Victor Biton, Selim R Benbadis, Bassel Shneker, Aashit K Shah

Epilepsy Behav· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Gregory Krauss, Victor Biton, Jay H Harvey, Christian Elger, Eugen Trinka

Epilepsy Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Victor Biton, Joanne B Rogin, Gregory Krauss, Bassel Abou-Khalil, José F Rocha

Epilepsy Behav· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.
Pavel Klein, Victor Biton, Deanne Dilley, Matthew Barnes, Jimmy Schiemann

Epilepsia· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials.
Victor Biton, Antonio Gil-Nagel, Jouko Isojarvi, Pamela Doty, David Hebert

Epilepsy Behav· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Deborah Lee, Uwa Kalu, Jonathan J Halford, Victor Biton, James Cloyd

Epilepsia· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy.
Dwain Tolbert, James Cloyd, Victor Biton, Ihor Bekersky, Mark Walzer

Epilepsia· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
Jacqueline French, Christian Brandt, Daniel Friedman, Victor Biton, Lloyd Knapp

Epilepsia· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.
Rajesh Sachdeo, Arnaud Partiot, Victor Biton, William E Rosenfeld, Virinder Nohria

Int J Clin Pharmacol Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Victor Biton, Samuel F Berkovic, Bassel Abou-Khalil, Michael R Sperling, Martin E Johnson

Epilepsia· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.
Victor Biton, Antonio Gil-Nagel, Martin J Brodie, Sarah E Derossett, Virinder Nohria

Epilepsy Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy.
Dorotheé G A Kasteleijn-Nolst Trenité, Victor Biton, Jacqueline A French, Bassel Abou-Khalil, William E Rosenfeld

Epilepsia· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis